Home
Live Updates
Amneal Reports First Quarter 2024 Financial Results : comparemela.com
Amneal Reports First Quarter 2024 Financial Results
‒ Q1 2024 Net Revenue of $659 million; GAAP Net Loss of $92 million; Diluted Loss per Share of $0.30 ‒
‒ Adjusted EBITDA of $152 million; Adjusted Diluted EPS of $0.14 ‒
‒ Company has...
Related Keywords
United States ,
American ,
America ,
Chintu Patel ,
Amneal Pharmaceuticals Inc ,
Kashiv Specialty Pharmaceuticals ,
Exchange Commission ,
Amneal Group ,
Drug Administration ,
Nasdaq ,
Saol International ,
Amneal Pharmaceuticals ,
Co Chief Executive ,
Nationwide Opioids ,
Native American Tribal Nations ,
Full Year ,
Eastern Time ,
Investor Relations ,
Securities Litigation Reform Act ,
Annual Report ,
Months Ended March ,
Cash Flows ,
Net Loss ,
Adjusted Net Income ,
Adjusted Diluted Earnings Per ,
Adjusted Diluted Earnings ,
Saol International Limited ,
Markets ,
comparemela.com © 2020. All Rights Reserved.